HCPCS Code Descriptor:
Injection, blinatumomab, 1 microgram
Route of Administration:
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
BLINCYTO is an Oncology drug manufactured by Amgen and administered via the Intravenous route of administration. The J Code: J9039 is aligned to the drug BLINCYTO.
Access Pricing and More By Registering
HCPCS Added Date:
HCPCS Effective Date:
HCPCS Short Description:
Billing and Coding Guide: